|
EDEM3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.522000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.921400E-01 |
| Normal-vs-Stage2 |
9.672000E-01 |
| Normal-vs-Stage3 |
5.881400E-01 |
| Normal-vs-Stage4 |
1.977190E-01 |
| Stage1-vs-Stage2 |
9.617800E-01 |
| Stage1-vs-Stage3 |
5.987600E-01 |
| Stage1-vs-Stage4 |
1.557030E-01 |
| Stage2-vs-Stage3 |
7.091600E-01 |
| Stage2-vs-Stage4 |
3.750600E-01 |
| Stage3-vs-Stage4 |
5.298000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.542800E-01 |
| Normal-vs-AfricanAmerican |
1.607960E-02 |
| Normal-vs-Asian |
9.163200E-01 |
| Caucasian-vs-AfricanAmerican |
3.183900E-03 |
| Caucasian-vs-Asian |
8.843200E-01 |
| AfricanAmerican-vs-Asian |
1.715410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.531800E-01 |
| Normal-vs-Female |
7.859400E-01 |
| Male-vs-Female |
6.790600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.423400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.028800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.450600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.905000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.086000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.359200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.396000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.896200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.629800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.723400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.451000E-01 |
| Normal-vs-Grade 2 |
6.167800E-01 |
| Normal-vs-Grade 3 |
1.364970E-01 |
| Normal-vs-Grade 4 |
2.647000E-01 |
| Grade 1-vs-Grade 2 |
6.012600E-01 |
| Grade 1-vs-Grade 3 |
5.946200E-02 |
| Grade 1-vs-Grade 4 |
1.236790E-01 |
| Grade 2-vs-Grade 3 |
1.999990E-02 |
| Grade 2-vs-Grade 4 |
8.338100E-02 |
| Grade 3-vs-Grade 4 |
9.993000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.340800E-01 |
| Normal-vs-ccB subtype |
8.273800E-01 |
| ccA subtype-vs-ccB subtype |
2.429200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.170200E-01 |
| Normal-vs-N1 |
8.912400E-01 |
| N0-vs-N1 |
8.726600E-01 |
|
|
